Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,293.60
(
0.67%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.52
(
-0.13%
)
Bitcoin
74,245.43
(
0.41%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 150088

Friday, 10/05/2012 11:58:48 AM

Friday, October 05, 2012 11:58:48 AM

Post# of 257253
B-I’s Rituxan-FoB trial was announced a few weeks ago (#msg-79555847). The ability to run a single trial for both the EU and US markets is a consequence of the EMA policy change posted in #msg-80049942.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now